Tokyo Pharma Chairman and Founder Acquires Company Shares
OKYO Pharma’s executive chairman–linked entity has increased its position in the company, with Panetta Partners acquiring 82,018 additional ordinary...
No videos found.
XOMA Announces Successful Lava Therapeutics Acquisition Deal
XOMA Royalty Corporation has completed its acquisition of Lava Therapeutics N.V., purchasing all outstanding shares for $1.04 in cash...
Mesoblast, BMT CTN Launch Pivotal Ryoncil GVHD Trial
Mesoblast will run a pivotal Phase 3 trial with the NIH-funded Blood and Marrow Transplant Clinical Trials Network to...
BioSyent Releases Financial Results for Q3 and YTD 2025
BioSyent posted double‑digit growth in Q3 2025, extending a profitable run built on in‑licensed, proven brands. Total company sales...
Scilex Update: Dream Bowl 2026 Meme Coin Distribution
DataVault AI plans to distribute “Dream Bowl 2026” meme coins to record holders of Scilex Holding Company common stock...
How Medical Information Is Transforming Into a Strategic, Tech-Enabled Partner in Rare Disease Care
At the 2025 Veeva Commercial Summit Europe, we spoke with Michelle Bridenbaker, Corporate Medical Information Lead at Recordati and...
Actimed Announces Important Licensing Deal with Mankind Pharma
Actimed Therapeutics has licensed exclusive rights to develop and commercialize its cachexia pipeline, including lead candidate s-pindolol benzoate (ACM-001.1),...
Anaptys Reveals a Remarkable $100 Million Stock Buyback Plan
AnaptysBio has expanded its stock repurchase capacity, authorizing up to $100 million of additional buybacks through March 31, 2026,...
Anaptys Files Lawsuit, A Challenge For GSK Subsidiary Tesaro
AnaptysBio has filed a verified complaint in Delaware Chancery Court alleging that Tesaro, now part of GSK, breached a...
Iovance Reports New Inducement Grants Under Nasdaq Rule
Iovance Biotherapeutics has granted inducement stock options covering 164,900 shares to 11 new non-executive employees, effective November 20, 2025....